How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

作者: Kristen K. Ciombor , Sigurdis Haraldsdottir , Richard M. Goldberg

DOI: 10.1007/S11888-014-0244-3

关键词:

摘要: Next-generation sequencing methods have exponentially increased the amount of genomic information available to scientists and clinicians. This review will explain evolution tumor gene identify its potential accelerate therapeutic progress by using colorectal cancer illustrate benefits this type analysis. A milestone in occurred when The Cancer Genome Atlas investigators characterized genomes 276 samples, with resulting expected provide future clinical applications help guide treatment cancer. Data regarding mutational frequencies, prognostic predictive biomarker usefulness, signaling pathway alterations are emerging from various next-generation platforms. also enhancing our understanding causes consequences both chromosomal instability microsatellite pathways as well expanding knowledge origins familial Limitations include need for storage analysis massive quantities data assurance that is highest possible quality. However, technology carries it revolutionize patients through better underlying disease biology subsequent development application approaches targeting genetic abnormalities specific individual malignancies.

参考文章(59)
Paul Roepman, Andreas Schlicker, Josep Tabernero, Ian Majewski, Sun Tian, Victor Moreno, Mireille H Snel, Christine M Chresta, Robert Rosenberg, Ulrich Nitsche, Teresa Macarulla, Gabriel Capella, Ramon Salazar, George Orphanides, Lodewyk FA Wessels, Rene Bernards, Iris M Simon, None, Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition International Journal of Cancer. ,vol. 134, pp. 552- 562 ,(2014) , 10.1002/IJC.28387
Lawrence A Donehower, Chad J Creighton, Nikolaus Schultz, Eve Shinbrot, Kyle Chang, Preethi H Gunaratne, Donna Muzny, Chris Sander, Stanley R Hamilton, Richard A Gibbs, David Wheeler, MLH1-silenced and non-silenced subgroups of hypermutated colorectal carcinomas have distinct mutational landscapes. The Journal of Pathology. ,vol. 229, pp. 99- 110 ,(2013) , 10.1002/PATH.4087
Jean-Pierre Issa, CpG island methylator phenotype in cancer Nature Reviews Cancer. ,vol. 4, pp. 988- 993 ,(2004) , 10.1038/NRC1507
Françoise Praz, Sandrine Jacob, Mélanie Aguado, David Fallik, The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Cancer Research. ,vol. 61, pp. 6555- 6562 ,(2001)
Tomomitsu Tahara, Eiichiro Yamamoto, Hiromu Suzuki, Reo Maruyama, Woonbok Chung, Judith Garriga, Jaroslav Jelinek, Hiro-o Yamano, Tamotsu Sugai, Byonggu An, Imad Shureiqi, Minoru Toyota, Yutaka Kondo, Marcos R.H. Estécio, Jean-Pierre J. Issa, Fusobacterium in colonic flora and molecular features of colorectal carcinoma Cancer Research. ,vol. 74, pp. 1311- 1318 ,(2014) , 10.1158/0008-5472.CAN-13-1865
Jeffrey A. Martin, Zhong Wang, Next-generation transcriptome assembly Nature Reviews Genetics. ,vol. 12, pp. 671- 682 ,(2011) , 10.1038/NRG3068
Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, Monique Goossens, Konnie M Hebeda, Marsha Voorendt, Tracy Y H Lee, Danielle Bodmer, Eveline Hoenselaar, Sandra J B Hendriks-Cornelissen, Wai Yin Tsui, Chi Kwan Kong, Han G Brunner, Ad Geurts van Kessel, Siu Tsan Yuen, J Han J M van Krieken, Suet Yi Leung, Nicoline Hoogerbrugge, Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 Nature Genetics. ,vol. 41, pp. 112- 117 ,(2009) , 10.1038/NG.283
Rachael Natrajan, Jorge S Reis-Filho, Next-generation sequencing applied to molecular diagnostics Expert Review of Molecular Diagnostics. ,vol. 11, pp. 425- 444 ,(2011) , 10.1586/ERM.11.18
C. I. Müller, K. Schulmann, A. Reinacher-Schick, N. Andre, D. Arnold, A. Tannapfel, H. Arkenau, S. A. Hahn, S. H.-J. Schmoll, R. Porschen, W. Schmiegel, U. Graeven, Predictive and prognostic value of microsatellite instability in patients with advanced colorectal cancer treated with a fluoropyrimidine and oxaliplatin containing first-line chemotherapy. A report of the AIO Colorectal Study Group International Journal of Colorectal Disease. ,vol. 23, pp. 1033- 1039 ,(2008) , 10.1007/S00384-008-0504-2
Andre Loboda, Michael V Nebozhyn, James W Watters, Carolyne A Buser, Peter Martin Shaw, Pearl S Huang, Laura Van't Veer, Rob AEM Tollenaar, David B Jackson, Deepak Agrawal, Hongyue Dai, Timothy J Yeatman, EMT is the dominant program in human colon cancer BMC Medical Genomics. ,vol. 4, pp. 9- 9 ,(2011) , 10.1186/1755-8794-4-9